Who is the manufacturer of PLANCET?

Micropoint Technologies Pte, Ltd. filed the 510(k) submission for PLANCET (K113513).

What is the FDA product code for PLANCET?

FMK. It is classified under 21 CFR 878.4850 as a Class 2 device in the General, Plastic Surgery panel.

What is the regulatory pathway for PLANCET?

510(k) clearance (submission type: Traditional).

Who can help prepare an FDA 510(k) submission like PLANCET?

Innolitics — a medical-device software consultancy — provides regulatory and engineering support for FDA 510(k) submissions. See https://innolitics.com/services/510ks/ or contact https://innolitics.com/contact.

PLANCET

Q: What are the predicate devices for PLANCET?

CLEANLET, CLEANLET XL & KIDS (K931827).

K113513 · Micropoint Technologies Pte, Ltd. · FMK · Jul 13, 2012 · General, Plastic Surgery

Device Facts

Record ID	K113513
Device Name	PLANCET
Applicant	Micropoint Technologies Pte, Ltd.
Product Code	FMK · General, Plastic Surgery
Decision Date	Jul 13, 2012
Decision	SESE
Submission Type	Traditional
Regulation	21 CFR 878.4850
Device Class	Class 2

Indications for Use

The PLANCET blood lancet is a puncture device to obtain micro-litre capillary whole blood samples from finger tips or palm or alternate body sites. The PLANCET blood lancet is normally loaded in a spring-operated lancing device for rapid puncture of skin.

Device Story

PLANCET is a single-use blood lancet designed for insertion into a spring-operated lancing device. Unlike traditional lancets using stainless steel needles, PLANCET utilizes a high-performance, bio-compatible plastic needle. The device consists of a needle encapsulated in a plastic body with a removable cap to maintain sterility until use. Operation involves removing the cap, loading the lancet into a spring-loaded lancing device, and triggering the mechanism to rapidly penetrate the skin. This creates a small wound to obtain a micro-liter capillary blood sample for point-of-care diagnostic tests, such as glucose or cholesterol monitoring. The device is intended for use by end-users in home settings or clinical environments. The plastic needle design provides sufficient strength for skin penetration while eliminating the risk of metal needle breakage in the skin.

Clinical Evidence

Bench testing and a focus group survey were conducted. Bench tests involved repeated penetration (4 times) of 0.4mm-thick polyurethane (PU) film to verify needle durability and strength. A blind focus group study of 18 people compared PLANCET to the predicate device, evaluating pain level and blood volume for glucose testing. Results indicated performance was comparable to the predicate, and all lancets remained intact post-use.

Technological Characteristics

Needle material: high-performance bio-compatible plastic (Elastic Modulus ~3.5 GPa). Body/cap material: polyethylene (PE). Sensing/actuation: mechanical puncture via spring-operated lancing device. Sterilization: terminal sterilization. Form factor: needle encapsulated in plastic body with removable cap.

Indications for Use

Indicated for patients requiring capillary whole blood samples from fingertips, palms, or alternate body sites for in-vitro diagnostic testing (e.g., glucose monitoring).

Regulatory Classification

Identification

The regulation covers four types of blood lancets: (a) Single use only blood lancet with an integral sharps injury prevention feature; (b) Single use only blood lancet without an integral sharps injury prevention feature; (c) Multiple use blood lancet for single patient use only; and (d) Multiple use blood lancet for multiple patient use. All are defined as disposable or reusable devices comprised of a blade attached to a base used to puncture the skin to obtain a drop of blood for diagnostic purposes.

Special Controls

*Classification.* Class II (special controls). The special controls are:(i) The design characteristics of the device must ensure that the structure and material composition are consistent with the intended use and must include a sharps injury prevention feature. (ii) Mechanical performance testing must demonstrate that the device will withstand forces encountered during use and that the integral sharps injury prevention feature will irreversibly disable the device after one use. (iii) The device must be demonstrated to be biocompatible. (iv) Sterility testing must demonstrate the sterility of any device component that breaches the skin ( *e.g.,* blade).(v) Labeling must include: (A) Detailed descriptions, with illustrations, of the proper use of the device and its sharps injury prevention feature. (B) Handwashing instructions for the user before and after use of the device. (C) Instructions on preparation ( *e.g.,* cleaning, disinfection) of the skin to be pierced.(D) Instructions for the safe disposal of the device. (E) Labeling must be appropriate for the intended use environment. ( *1* ) For those devices intended for health care settings, labeling must address the health care facility use of these devices, including how these lancets are to be used with personal protective equipment, such as gloves.( *2* ) For those devices intended for use in the home, labeling must be written so that it is understandable to lay users.(vi) Labeling must also include the following statements, prominently placed: (A) “For use only on a single patient. Discard the entire device after use.” (B) “Warning: Not intended for more than one use. Do not use on more than one patient. Improper use of blood lancets can increase the risk of inadvertent transmission of bloodborne pathogens, particularly in settings where multiple patients are tested.” (b) *Single use only blood lancet without an integral sharps injury prevention feature* —(1)*Identification.* A disposable blood lancet intended for a single use that is comprised of a single use blade attached to a solid, non-reusable base that is used to puncture the skin to obtain a drop of blood for diagnostic purposes.(2) *Classification.* Class II (special controls). The special controls are:(i) The design characteristics of the device must ensure that the structure and material composition are consistent with the intended use and address the risk of sharp object injuries and bloodborne pathogen transmissions. (ii) Mechanical performance testing must demonstrate that the device will withstand forces encountered during use. (iii) The device must be demonstrated to be biocompatible. (iv) Sterility testing must demonstrate the sterility of any device component that breaches the skin ( *e.g.,* blade).(v) Labeling must include: (A) Detailed descriptions, with illustrations, of the proper use of the device. (B) Handwashing instructions for the user before and after use of the device. (C) Instructions on preparation ( *e.g.,* cleaning, disinfection) of the skin to be pierced.(D) Instructions for the safe disposal of the device. (E) Labeling must be appropriate for the intended use environment. ( *1* ) For those devices intended for health care settings, labeling must address the health care facility use of these devices, including how these lancets are to be used with personal protective equipment, such as gloves.( *2* ) For those devices intended for use in the home, labeling must be written so that it is understandable to lay users.(vi) Labeling must also include the following statements, prominently placed: (A) “For use only on a single patient. Discard the entire device after use.” (B) “Warning: Not intended for more than one use. Do not use on more than one patient. Improper use of blood lancets can increase the risk of inadvertent transmission of bloodborne pathogens, particularly in settings where multiple patients are tested.” (c) *Multiple use blood lancet for single patient use only* —(1)*Identification.* A multiple use capable blood lancet intended for use on a single patient that is comprised of a single use blade attached to a solid, reusable base that is used to puncture the skin to obtain a drop of blood for diagnostic purposes.(2) *Classification.* Class II (special controls). The special controls are:(i) The design characteristics of the device must ensure that: (A) The lancet blade can be changed with every use, either manually or by triggering a blade storage unit to discard the used blade and reload an unused blade into the reusable base; and (B) The structure and material composition are consistent with the intended use and address the risk of sharp object injuries and bloodborne pathogen transmissions and allow for validated cleaning and disinfection. (ii) Mechanical performance testing must demonstrate that the device will withstand forces encountered during use. (iii) The device must be demonstrated to be biocompatible. (iv) Sterility testing must demonstrate the sterility of any device component that breaches the skin ( *e.g.,* blade).(v) Validation testing must demonstrate that the cleaning and disinfection instructions are adequate to ensure that the reusable lancet base can be cleaned and low level disinfected. (vi) Labeling must include: (A) Detailed descriptions, with illustrations, of the proper use of the device. (B) The Environmental Protection Agency (EPA) registered disinfectant's contact time for disinfectant use. (C) Handwashing instructions for the user before and after use of the device. (D) Instructions on preparation ( *e.g.,* cleaning, disinfection) of the skin to be pierced.(E) Instructions on the cleaning and disinfection of the device. (F) Instructions for the safe disposal of the device. (G) Instructions for use must address the safe storage of the reusable blood lancet base between uses to minimize contamination or damage and the safe storage and disposal of the refill lancet blades. (H) Labeling must be appropriate for the intended use environment. ( *1* ) For those devices intended for health care settings, labeling must address the health care facility use of these devices, including how these lancets are to be used with personal protective equipment, such as gloves.( *2* ) For those devices intended for use in the home, labeling must be written so that it is understandable to lay users.(vii) Labeling must also include the following statements, prominently placed: (A) “For use only on a single patient. Disinfect reusable components according to manufacturer's instructions between each use.” (B) “Used lancet blades must be safely discarded after a single use.” (C) “Warning: Do not use on more than one patient. Improper use of blood lancets can increase the risk of inadvertent transmission of bloodborne pathogens, particularly in settings where multiple patients are tested. The cleaning and disinfection instructions for this device are intended only to reduce the risk of local use site infection; they cannot render this device safe for use for more than one patient.” (d) *Multiple use blood lancet for multiple patient use* —(1)*Identification.* A multiple use capable blood lancet intended for use on multiple patients that is comprised of a single use blade attached to a solid, reusable base that is used to puncture the skin to obtain a drop of blood for diagnostic purposes.(2) *Classification.* Class III (premarket approval).(3) *Date PMA or notice of completion of a PDP is required:* A PMA or a notice of completion of a PDP is required to be filed with the Food and Drug Administration on or before May 22, 2024, for any multiple use blood lancet for multiple patient use described in paragraph (d)(1) of this section that was in commercial distribution before May 28, 1976, or that has, on or before May 22, 2024, been found to be substantially equivalent to a multiple use blood lancet for multiple patient use described in paragraph (d)(1) of this section that was in commercial distribution before May 28, 1976. Any other multiple use blood lancet for multiple patient use shall have an approved PMA or a declared completed PDP in effect before being placed in commercial distribution.

Predicate Devices

CLEANLET, CLEANLET XL & KIDS (K931827)

Submission Summary (Full Text)

{0}------------------------------------------------ ## K113513 # Page 1 of 3 ### 5. 510 (k) Summary JUL 1 3 2012 | Owner's Name: | Micropoint Technologies Pte Ltd | |--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Address: | 11, Kallang Place, #06-10/12 Singapore 339155 | | Telephone Number: | +65 6777 0573 | | Facsimile Number: | +65 6777 0573 | | Name of Contact Person: | Mr Chee Yen Lim | | Date: | 31 August 2011 | | Trade/Proprietary Name: | PLANCET | | Common Name: | Blood Lancet | | Class: | Class I (Exempt) | | Classification Name: | Lancet, Blood (Product Code: FMK, Regulation No. 878.4800) | | Legally Marketed Predicate Device | CLEANLET, CLEANLET XL & KIDS (K931827 ) | | Description of the Device: | The PLANCET blood lancet is a needle device to be loaded in a lancing device for pricking a patient's finger or palm to draw a micro-litre sample of whole blood to perform in-vitro diagnostic (IVD) blood tests. Most point-of-care (POC) IVD devices rely on micro-sample quantities of capillary whole blood to carry out the analysis on the blood content, which may include glucose concentration, cholesterol level, and the absence or presence of antigens and antibodies. Blood lancets are commonly used by end users who regularly perform the IVD tests at home, such a glucose monitoring tests. The predicate device normally has a stainless steel needle encapsulated by a plastic material to form a body and a cap. This encapsulation ensures the needle integrity and sterility till point of use. To use the device, the user will twist off the cap to expose the needle and load the device into a spring operated lancing device. The device will be actuated and retracted rapidly to penetrate the skin and create a small wound on the skin for getting some capillary whole blood. More volume of blood can be obtained by compressing or massaging (milking) the lanced site. On the other hand, the PLANCET has exactly the same design, i.e. a needle that is encapsulated by a plastic material that forms a body and a cap. This plastic encapsulation ensures the needle's | | | integrity and sterility till point of use. However, in this case, the needle is also made of a plastic material. The procedure to use PLANCET is to pull off the cap and to load PLANCET into a spring operated lancing device. Once triggered, the PLANCET will be actuated and retracted rapidly to penetrate the skin and create a small wound for getting some capillary whole blood. | | Indications for Use/ Intended Use: | The PLANCET blood lancet is a puncture device to obtain micro- litre capillary whole blood samples from finger tips or palm or alternate body sites. The PLANCET blood lancet is normally loaded in a spring-operated lancing device for rapid puncture of skin. | | Technological Characteristics of the Device | Manufacturing aspects: The manufacturing process of the predicate device comprises stainless steel needle fabrication and plastic over-moulding. Stainless steel wires are cut into small lengths and ground sharp, after which they are de-burred and polished by an electro- chemical process. Optionally, the ground needles can be coated with a layer of silicone lubricant. Finally, the ground needles are fed into an injection moulding machine to over-mould plastic materials e.g. polyethylene (PE) forming a body and a cap, encapsulating the ground needles. Terminal sterilization process is performed to ensure sterility of entire products. Note that the high temperature of the moulding process may sterilize the needles and keep the sterile condition intact until the cap is twisted off. The manufacturing of PLANCET comprises injection moulding of plastic needles and plastic over-moulding using polyethylene PE (exactly the same process as involved in the predicate device). Instead of cutting wire into small lengths, grinding and polishing needles, one single injection moulding process is used to fabricate the plastic needles. The plastic material is a high performance and bio-compatible plastic material. | | | Design & Functionality aspects: The predicate device comprises a stainless steel needle encapsulated with a plastic body and a cap, the cap is twisted off to expose the needle for use. The predicate device is normally loaded into a spring-operated lancing device, which rapidly penetrates the skin to obtain micro-litre sample of capillary whole blood. | | | The PLANCET has exactly the same design and functionality as compared with the predicate device. One minute difference will be instead of twisting off the cap to expose the needle, the | | PLANCET requires the end user to pull off the cap, which is a simpler procedure. | | | Materials aspects: The predicate device has a needle that is made of stainless steel and a body and a cap that are made of plastic materials such as polyethylene (PE). The stainless steel material is bio-compatible and has Elastic Modulus of roughly 200 GPa. | | | The PLANCET has a needle that is made of high performance and bio-compatible plastic material and a body and a cap that are made of plastic materials such as polyethylene (PE). The high performance and bio-compatible plastic material has Elastic Modulus of roughly 3.5 GPa. These needles have sufficient strength for the use of pricking fingers and palms. | | | Non-Clinical Performance Data | | | Bench tests: The durability and strength of the plastic needles were tested in a series of penetration tests using the PLANCET blood lancets loaded in a spring-operated lancing device and a 0.4mm-thick polyurethane (PU) film. Our data show that the PLANCET blood lancets are able to penetrate the PU film repeatedly without damage to the needle tip or body. | | | Focus group survey: To test the performance (pain level and blood volume) of the PLANCET blood lancets in actual use, a focus group of 18 people was established to conduct a blind study involving a predicate device and the PLANCET. The results showed that the pain level and the blood volume for carrying out a glucose test are comparable to the predicate device. All PLANCET blood lancets were inspected under magnification, and all PLANCET blood lancets remained intact. | | | Our study shows that the PLANCET blood lancets when used with a spring-operated lancing device have comparable functionality performance compared to the predicate device. In particular, the PLANCET blood lancets can penetrate repeatedly (4 times) a thick and hard PU film without damage, ruling out the possibility that they will break and remain in the skin. Our study also shows that PLANCET blood lancets when used with a spring-operated lancing device can obtain sufficient blood for carrying out a glucose test. | | | Conclusions | | | Drawing conclusions from our non-clinical data, the PLANCET blood lancets are substantially similar to the predicate device in terms of performance and are safe and effective for the intended | | 10 {1}------------------------------------------------ ## K 11 35 13 Page 2 of 3 11 : 上 {2}------------------------------------------------ K 11 35 13 Page 3 of 3 12 {3}------------------------------------------------ ### DEPARTMENT OF HEALTH & HUMAN SERVICES Image /page/3/Picture/1 description: The image is a black and white circular logo for the U.S. Department of Health & Human Services. The logo features a stylized image of an eagle with its wings spread, and three wave-like lines below it. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged around the top half of the circle. Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002 Micropoint Technologies PTE, Limited % Mr. Chee Yen Lim 11. Kallang Place #06-10/12 Singapore, Singapore 339155 JUL 13 2012 Re: K113513 Trade/Device Name: PLANCET Blood Lancet Regulation Number: 21 CFR 878.4800 Regulation Name: Manual surgical instrument for general use Regulatory Class: I Product Code: FMK Dated: June 14, 2012 Received: June 18, 2012 Dear Mr. Lim: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 {4}------------------------------------------------ Page 2 - Mr. Chee Yen Lim CFR Part 807): labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm Sincerely yours, Mark N. Melkerson Director Division of Surgical, Orthopedic and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {5}------------------------------------------------ Page 1 of 1 #### 4. Indications for Use Statement 0(k) Number (if known): K113513 Device Name: PLANCET Blood Lancet Indications for Use: The PLANCET blood lancet is a puncture device to obtain micro-litte capillary whole blood samples from finger tips or palm or alternate body sites. The PLANCET blood lancet is normally loaded in a spring-operated lancing device for rapid puncture of skin. Prescription Use (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use X (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Nilk Doyle for mxm (Division Sign-Off) Division of Surgical. Orthopedic, and Restorative Devices 510(k) Number K. 113513 9

PLANCET

Device Facts

Indications for Use

Device Story

Clinical Evidence

Technological Characteristics

Indications for Use

Regulatory Classification

Identification

Special Controls

Predicate Devices

Submission Summary (Full Text)

Panel 1

Section Matches

Product Code Matches

Special Control Matches

My Alerts

PLANCET

Device Facts

Indications for Use

Device Story

Clinical Evidence

Technological Characteristics

Indications for Use

Regulatory Classification

Identification

Special Controls

Predicate Devices

Submission Summary (Full Text)

Panel 1

Section Matches

Product Code Matches

Special Control Matches

My Alerts

Create Alert

Search Filters

Agent Token

Connected apps